Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative assessment and patient selection

Nontreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When a surgical correction is not feasible due to high operative risk, transcatheter treatment of the tricuspid valve has been suggested as an interesting valuable option. Caval valve implantation has been proposed to overcome the tricuspid valve regurgitation mechanism reducing the effect of insufficiency on the splanchnic systems. Given the technical simplicity of the caval valve implantation technique when compared with other transcatheter devices, it is a suitable option for a wide variety of patients. Eligibility criteria and patient selection are still matter of debate. We hereby describe the case of a patient successfully treated with bicaval implants with regard to preoperative assessment.